Repligen Corp
XMUN:RGN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Repligen Corp
XMUN:RGN
|
US |
|
Medacta Group SA
F:6MD
|
CH |
|
China Aviation Oil (Singapore) Corporation Ltd
OTC:CAOLF
|
SG |
|
Delivra Health Brands Inc
F:3F0
|
CA |
|
B
|
Bangkok Post PCL
SET:POST
|
TH |
|
P
|
PetroChina Co Ltd
F:PC6A
|
CN |
|
Forward Air Corp
F:FA2
|
US |
Wall St Price Targets
RGN Price Targets Summary
Repligen Corp
According to Wall Street analysts, the average 1-year price target for RGN is 151.6 EUR with a low forecast of 118.86 EUR and a high forecast of 191.45 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGN's stock price target?
Price Target
151.6
EUR
According to Wall Street analysts, the average 1-year price target for RGN is 151.6 EUR with a low forecast of 118.86 EUR and a high forecast of 191.45 EUR.
What is the Revenue forecast for Repligen Corp?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 8 years is 17%.
What is the Operating Income forecast for Repligen Corp?
Projected CAGR
31%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 8 years is 31%.
What is the Net Income forecast for Repligen Corp?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 30%.
